Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
313.69
+0.87 (+0.28%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
42
43
Next >
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amgen Inc. (AMGN)
March 21, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
These Are The Top 3 Large Caps For Yield And Dividend Growth
March 21, 2023
You can use Marketbeat's Dividend Screener to find top dividend growth stocks with yields above 3% and value for investors.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Looking At Amgen's Recent Unusual Options Activity
March 20, 2023
Via
Benzinga
3 Dow Stocks Near 52-Week Lows That Look Like Bargains Now
March 20, 2023
These businesses are performing much better than their stock prices would suggest.
Via
The Motley Fool
AMGEN INC. (NASDAQ: AMGN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amgen Inc. (NASDAQ: AMGN)
March 20, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Amgen Unusual Options Activity For March 15
March 15, 2023
Via
Benzinga
ROSEN, A LEADING LAW FIRM, Encourages Amgen Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AMGN
March 19, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Regulatory Compliance
Exposures
Financial
Legal
Regulatory
AMGN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Securities Class Action Lawsuit Against Amgen Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Lawsuit
March 18, 2023
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Match, Credit Suisse, SVB, and Amgen and Encourages Investors to Contact the Firm
March 17, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Price Over Earnings Overview: Amgen
March 15, 2023
Via
Benzinga
2 Top Biotech Stocks to Buy Right Now
March 15, 2023
These two companies are showering shareholders with market-topping payouts.
Via
The Motley Fool
Bronstein, Gewirtz & Grossman, LLC Notifies Amgen Inc. (AMGN) Investors of Class Action and to Actively Participate
March 17, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Attention Amgen Inc. (AMGN) Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against Amgen Inc. and Encourages Investors with Significant Losses to Contact the Firm
March 16, 2023
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
Amgen Faces Lawsuit For Hiding Its Stupendous Tax Bill Of $10B
March 14, 2023
Via
Benzinga
Amgen's Debt Overview
March 14, 2023
Via
Benzinga
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Amgen Inc. (AMGN) Investors
March 16, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Amgen Inc. (AMGN) Investors
March 16, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Amgen Inc. (AMGN) Investors
March 16, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Amgen Inc. (AMGN) Investors of Class Action and to Actively Participate
March 16, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amgen Inc. (AMGN) on Behalf of Investors
March 16, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
Is It Time to Buy the Dow Jones' 3 Worst-Performing February (and Now March) Stocks?
March 16, 2023
Several blue chips have been routed lately, but most of their sell-offs were way overdone.
Via
The Motley Fool
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Amgen Inc. (AMGN) on Behalf of Investors
March 15, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
AMGEN INC. (NASDAQ: AMGN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Amgen Inc. (NASDAQ: AMGN)
March 15, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
March 15, 2023
From
The Schall Law Firm
Via
Business Wire
AMGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Amgen Inc. and Encourages Investors to Contact the Firm
March 14, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Amgen Inc. (AMGN) on Behalf of Investors
March 14, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
March 14, 2023
From
The Schall Law Firm
Via
Business Wire
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Amgen Inc. (AMGN)
March 14, 2023
From
Robbins LLP
Via
Business Wire
Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
March 14, 2023
Avid Bioservices Inc. (NASDAQ: CDMO) is a contract development and manufacturing organization (CDMO) that specializes in producing monoclonal antibodies,
Via
MarketBeat
Exposures
COVID-19
AMGN EQUITY ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Amgen Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – AMGN
March 14, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
42
43
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.